Mark Reihill is a final year chemistry PhD researcher at University College Dublin, specializing in the synthesis of complex glycan structures and glycoconjugates for biological evaluation under the supervision of Professor Stefan Oscarson. With prior experience as a Development Chemist at Thermo Fisher Scientific, Mark has also held various roles at Pfizer, including Chemistry Team Leader. Mark earned a Bachelor of Science in Medicinal Chemistry and Chemical Biology from University College Dublin.
This person is not in the org chart
This person is not in any teams
This person is not in any offices